Described two new variants of the TLR7 gene associated with severe COVID-19 in young and healthy men

by Hospital Universitari de Bellvitge

Older age, being a male, or suffering from certain chronic diseases such as diabetes or obesity has been linked to the development of severe forms of COVID-19. Now, a new study published in the journa...

Read more

IMIDomics, a Vall d'Hebron spin-off, raises $16.5 million to develop new drugs against immunomediated inflammatory diseases

by Vall d’Hebron

This investment will allow IMIDomics to accelerate the identification of new therapeutic targets and the development of new drugs for immune-mediated inflammatory diseases (IMID), like rheumatoid arth...

Read more

PROYECTO HIPERNAV| Un estudio pionero consigue mayor precisión en las cirugías de cáncer de hígado

by Universidad de Córdoba

El proyecto Hipernav ha empleado el casco Hololens de Microsoft en el campo clínico para afinar la precisión durante la extirpación de tumores

Read more

Machine learning fuels personalised cancer medicine

by IRB Barcelona - Instituto de Investigación Biomédica

The Biomedical Genomics laboratory at IRB Barcelona has developed a computational tool that identifies cancer driver mutations for each tumour type. This and other developments produced by the same l...

Read more

La impronta inmunológica condiciona la respuesta al SARS-CoV-2

by Hospital Universitari de Bellvitge

Un estudio del Hospital de Bellvitge, el IDIBELL y la Icahn School of Medicine de Mount Sinai, en Nueva York publicado en la revista Nature Communications, ha demostrado por primera vez que el fenóme...

Read more

Development of a new system for detection of antibodies against SARS-CoV-2 by researchers from the CBGP

by Centro de Biotecnología y Genómica de Plantas CBGP

SARS-CoV-2 virus is tha infectious agent causing the COVID-19 pandemic, which has swept across the whole world during these last two years, rendering more than 195 millions of infected people and more...

Read more

New strategies to fight aggressive breast cancer

by Vall d’Hebron

CIBER-BBN and VHIR researchers design a new system to transport a drug effective against tumour stem cells, the most resistant ones, through nanoparticles.

Read more

by Labo'Life
  • 3 years ago

Read more

New advances in the characterization of the minority disease Limfangioleiomyomatosis

by Hospital Universitari de Bellvitge

This is a very heterogeneous disease that shares traits with cancer, and it characterizes by the proliferation of cells that can damage the lung tissue.

Read more

Sant Pau researchers advance in the knowledge of the most common chronic inflammatory neuropathy

by Hospital de la Santa Creu i Sant Pau

​ Dr Elba Pascual-Goñi, researcher of the Neuromuscular Diseases Group of the Research Institute of the Hospital de la Santa Creu i Sant Pau – IIB Sant Pau has described a new subgroup of pati...

Read more

IDIBELL scientists identify the PI4KA gene as the cause of a new neurological disease

by Hospital Universitari de Bellvitge

This new rare disorder causes a range of symptoms including global delay in brain development, epilepsy, and defects in myelin and the immune system.

Read more
Subscribe to Directory
Write an Article

Recent News

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Un estudio de INCLIVA muestra el efecto ...

by INCLIVA

Han desarrollado un estudio para evaluar la correlación entre el teji...

Photos Stream